By Judith Kares, JD, CPC, regulatory specialist for HCPro, Inc
CMS recently issued Medicare Claims Processing Manual Transmittal 1799 (CR 6570), which is a Recurring Update Notification to inform contractors of new waived tests approved by the Food and Drug Administration under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Since these tests are marketed immediately after approval, CMS must notify its contractors of the new tests so that the contractors can accurately process claims. This seems like a good time to review the basic guidelines set out under CLIA with respect to waived tests.


